The first ABO-incompatible kidney transplantation performed in Portugal

Bibliographic Details
Main Author: Barreto,Patricia
Publication Date: 2015
Other Authors: Vieira,Pedro, Dias,Leonidio, Almeida,Manuela, Pedroso,Sofia, Martins,La Salete, Henriques,Antonio Castro, Bini,Marika, Cabrita,Antonio
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000400009
Summary: Kidney transplantation is the optimal treatment of end -stage renal disease (ESRD) improving survival and quality of life for most recipients. In our country, potential living donors have been refused due to the ABO incompatibility barrier. However, ABO -incompatible living donor kidney transplant is presently common practice in several countries with good outcomes. The authors describe a case of a 49 -year -old female patient, with chronic kidney disease due to autosomal dominant polycystic kidney disease, who had started haemodialysis 10 months before and with blood group O. The living donor was a 53-year-old sister with blood group B. The desensitization protocol was based on rituximab and plasmapheresis. The induction protocol used was basiliximab, tacrolimus, mofetil mycophenolate and metilprednisolone. Five days post -transplant she presented a normal graft function that remained during the eight months follow -up. This case reveals the first ABO incompatible living donor kidney transplant performed in Portugal with excellent outcome
id RCAP_f75abc655315053e3503a99d7dbc88a3
oai_identifier_str oai:scielo:S0872-01692015000400009
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling The first ABO-incompatible kidney transplantation performed in PortugalABO-incompatibilitykidney transplantationliving donorKidney transplantation is the optimal treatment of end -stage renal disease (ESRD) improving survival and quality of life for most recipients. In our country, potential living donors have been refused due to the ABO incompatibility barrier. However, ABO -incompatible living donor kidney transplant is presently common practice in several countries with good outcomes. The authors describe a case of a 49 -year -old female patient, with chronic kidney disease due to autosomal dominant polycystic kidney disease, who had started haemodialysis 10 months before and with blood group O. The living donor was a 53-year-old sister with blood group B. The desensitization protocol was based on rituximab and plasmapheresis. The induction protocol used was basiliximab, tacrolimus, mofetil mycophenolate and metilprednisolone. Five days post -transplant she presented a normal graft function that remained during the eight months follow -up. This case reveals the first ABO incompatible living donor kidney transplant performed in Portugal with excellent outcomeSociedade Portuguesa de Nefrologia2015-12-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000400009Portuguese Journal of Nephrology & Hypertension v.29 n.4 2015reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000400009Barreto,PatriciaVieira,PedroDias,LeonidioAlmeida,ManuelaPedroso,SofiaMartins,La SaleteHenriques,Antonio CastroBini,MarikaCabrita,Antonioinfo:eu-repo/semantics/openAccess2024-02-06T17:04:50Zoai:scielo:S0872-01692015000400009Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T12:54:26.902386Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv The first ABO-incompatible kidney transplantation performed in Portugal
title The first ABO-incompatible kidney transplantation performed in Portugal
spellingShingle The first ABO-incompatible kidney transplantation performed in Portugal
Barreto,Patricia
ABO-incompatibility
kidney transplantation
living donor
title_short The first ABO-incompatible kidney transplantation performed in Portugal
title_full The first ABO-incompatible kidney transplantation performed in Portugal
title_fullStr The first ABO-incompatible kidney transplantation performed in Portugal
title_full_unstemmed The first ABO-incompatible kidney transplantation performed in Portugal
title_sort The first ABO-incompatible kidney transplantation performed in Portugal
author Barreto,Patricia
author_facet Barreto,Patricia
Vieira,Pedro
Dias,Leonidio
Almeida,Manuela
Pedroso,Sofia
Martins,La Salete
Henriques,Antonio Castro
Bini,Marika
Cabrita,Antonio
author_role author
author2 Vieira,Pedro
Dias,Leonidio
Almeida,Manuela
Pedroso,Sofia
Martins,La Salete
Henriques,Antonio Castro
Bini,Marika
Cabrita,Antonio
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Barreto,Patricia
Vieira,Pedro
Dias,Leonidio
Almeida,Manuela
Pedroso,Sofia
Martins,La Salete
Henriques,Antonio Castro
Bini,Marika
Cabrita,Antonio
dc.subject.por.fl_str_mv ABO-incompatibility
kidney transplantation
living donor
topic ABO-incompatibility
kidney transplantation
living donor
description Kidney transplantation is the optimal treatment of end -stage renal disease (ESRD) improving survival and quality of life for most recipients. In our country, potential living donors have been refused due to the ABO incompatibility barrier. However, ABO -incompatible living donor kidney transplant is presently common practice in several countries with good outcomes. The authors describe a case of a 49 -year -old female patient, with chronic kidney disease due to autosomal dominant polycystic kidney disease, who had started haemodialysis 10 months before and with blood group O. The living donor was a 53-year-old sister with blood group B. The desensitization protocol was based on rituximab and plasmapheresis. The induction protocol used was basiliximab, tacrolimus, mofetil mycophenolate and metilprednisolone. Five days post -transplant she presented a normal graft function that remained during the eight months follow -up. This case reveals the first ABO incompatible living donor kidney transplant performed in Portugal with excellent outcome
publishDate 2015
dc.date.none.fl_str_mv 2015-12-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000400009
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000400009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000400009
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
dc.source.none.fl_str_mv Portuguese Journal of Nephrology & Hypertension v.29 n.4 2015
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833593236503920640